Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery Wins SBIR Grant for Cancer Genome Atlas Platform, Partners with Huntsman

NEW YORK (GenomeWeb) – Genomic analysis software maker BioDiscovery said today it will use a $157,000 grant from the National Cancer Institute to analyze and improve copy number variant data from The Cancer Genome Atlas program.

The Small Business Innovation Research grant will fund efforts to develop and commercialize CNV and sequence variant data that researchers will use in studies of tumorigenesis and disease progression, and which will provide a validation set for use in international studies.

The Hawthorne, Calif.-based company said the Huntsman Cancer Institute (NCI) and the University of Utah will help it develop and validate the cancer data offering that it aims take to market.

BioDiscovery offers tools for analyzing and visualizing data from next-generation sequencing and microarray platforms, including its flagship Nexus Copy Number software.

"We are applying methods, algorithms, and best practices learned from our experiences in clinical pathology settings to TCGA data," Soheil Shams, BioDiscovery's Chief Scientific Officer, said in a statement. "It's a painstaking process, but the result will be the highest-fidelity CNV data from TCGA, and will integrate with our analysis platform to let researchers quickly access and interrogate this database."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.